Hemogenyx Pharmaceuticals PLC (HEMO) — Free Cash Flow Generation Index

Latest as of June 2017: 0.53x

Hemogenyx Pharmaceuticals PLC (HEMO) has a Free Cash Flow Generation Index of 0.53x as of June 2017. Free cash flow of GBX12.24 represents 1% of operating cash flow (GBX23.26). Explore HEMO capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.53x

Free Cash Flow / Operating CF

Free Cash Flow

GBX12.24

GBX

Operating Cash Flow

GBX23.26

GBX

Capital Expenditures

GBX11.02

GBX

Hemogenyx Pharmaceuticals PLC Free Cash Flow Generation Index (2015–2015)

Historical FCF Generation Index trend for Hemogenyx Pharmaceuticals PLC across 1 annual periods. For the full cash flow conversion analysis, see Hemogenyx Pharmaceuticals PLC (HEMO) cash conversion ratio.

Annual Free Cash Flow Generation for Hemogenyx Pharmaceuticals PLC (2015–2015)

Year-by-year Free Cash Flow Generation Index for Hemogenyx Pharmaceuticals PLC. Check Hemogenyx Pharmaceuticals PLC investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year	FCG Index	Free Cash Flow (GBX)	Operating CF	Capital Expenditures	YoY Change
2015	1.00x	GBX79.71	GBX79.71	GBX0.00	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).